BIOM at an all time low because they didn't have results good enough to quit a trial early. They were good enough to continue the trial to its designed end, however.
A new PII was also announced.
News was positive, panic is absurd, a common pattern with biotech news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.